113 related articles for article (PubMed ID: 28986060)
1. The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease.
Nilsen DWT; Aarsetoey H; Pönitz V; Brugger-Andersen T; Staines H; Harris WS; Grundt H
Int J Cardiol; 2017 Dec; 249():12-17. PubMed ID: 28986060
[TBL] [Abstract][Full Text] [Related]
2. Decreased circulating dihomo-gamma-linolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure.
Ouchi S; Miyazaki T; Shimada K; Sugita Y; Shimizu M; Murata A; Kato T; Aikawa T; Suda S; Shiozawa T; Hiki M; Takahashi S; Kasai T; Miyauchi K; Daida H
Lipids Health Dis; 2017 Aug; 16(1):150. PubMed ID: 28806965
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction.
Nilsen DWT; Myhre PL; Kalstad A; Schmidt EB; Arnesen H; Seljeflot I
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684479
[TBL] [Abstract][Full Text] [Related]
4. Serum dihomo-γ-linolenic acid level is inversely associated with the risk of depression. A 21-year follow-up study in general population men.
Yary T; Tolmunen T; Lehto SM; Tuomainen TP; Nurmi T; Kauhanen J; Voutilainen S; Ruusunen A
J Affect Disord; 2017 Apr; 213():151-155. PubMed ID: 28235735
[TBL] [Abstract][Full Text] [Related]
5. Low Docosahexaenoic Acid, Dihomo-Gamma-Linolenic Acid, and Arachidonic Acid Levels Associated with Long-Term Mortality in Patients with Acute Decompensated Heart Failure in Different Nutritional Statuses.
Ouchi S; Miyazaki T; Shimada K; Sugita Y; Shimizu M; Murata A; Kato T; Aikawa T; Suda S; Shiozawa T; Hiki M; Takahashi S; Iwata H; Kasai T; Miyauchi K; Daida H
Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867781
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome.
Mjelva OR; Brügger-Andersen T; Pönitz V; Grundt H; Kontny F; Staines H; Nilsen DW
Scand Cardiovasc J; 2013 Apr; 47(2):88-97. PubMed ID: 23406538
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
[TBL] [Abstract][Full Text] [Related]
8. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
Bonaca MP; O'Malley RG; Murphy SA; Jarolim P; Conrad MJ; Braunwald E; Sabatine MS; Morrow DA
Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):431-40. PubMed ID: 25538086
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome].
Zhang JH; Wang CH; Xu J; Ye L; Wang XC; Xu BL; Chen XH; Wu MZ; Cheng ZP; Xu Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):305-310. PubMed ID: 31060190
[No Abstract] [Full Text] [Related]
10. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
[TBL] [Abstract][Full Text] [Related]
11. Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.
Etaher A; Chew D; Redfern J; Briffa T; Ellis C; Hammett C; Lefkovits J; Elliott J; Cullen L; Brieger D; French JK
Heart Lung Circ; 2017 Oct; 26(10):1051-1058. PubMed ID: 28139353
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy.
Giannitsis E; Wallentin L; James SK; Bertilsson M; Siegbahn A; Storey RF; Husted S; Cannon CP; Armstrong PW; Steg PG; Katus HA;
Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):500-510. PubMed ID: 27044282
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.
Dhillon OS; Khan SQ; Narayan HK; Ng KH; Mohammed N; Quinn PA; Squire IB; Davies JE; Ng LL
Clin Sci (Lond); 2009 Nov; 118(4):249-57. PubMed ID: 19583569
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial.
Acharji S; Baber U; Mehran R; Fahy M; Kirtane AJ; Lansky AJ; Stone GW
Circ Cardiovasc Interv; 2012 Apr; 5(2):157-65. PubMed ID: 22354934
[TBL] [Abstract][Full Text] [Related]
15. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
Oemrawsingh RM; Lenderink T; Akkerhuis KM; Heeschen C; Baldus S; Fichtlscherer S; Hamm CW; Simoons ML; Boersma E;
Heart; 2011 Jul; 97(13):1061-6. PubMed ID: 21558475
[TBL] [Abstract][Full Text] [Related]
16. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.
Farhan S; Clare RM; Jarai R; Giugliano RP; Lokhnygina Y; Harrington RA; Kristin Newby L; Huber K
Int J Cardiol; 2017 Apr; 232():264-270. PubMed ID: 28089149
[TBL] [Abstract][Full Text] [Related]
17. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
[TBL] [Abstract][Full Text] [Related]
18. (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome.
Aarsetoey H; Pönitz V; Grundt H; Staines H; Harris WS; Nilsen DW
J Nutr; 2009 Mar; 139(3):507-13. PubMed ID: 19158216
[TBL] [Abstract][Full Text] [Related]
19. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome.
Taglieri N; Saia F; Rapezzi C; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Ortolani P; Melandri G; Rosmini S; Cinti L; Alessi L; Vagnarelli F; Villani C; Branzi A; Marzocchi A
Thromb Haemost; 2011 Jul; 106(1):132-40. PubMed ID: 21614413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
